Procarbazine
Clinical data | |
---|---|
Trade names | Matulane, Natulan, Indicarb, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682094 |
Pregnancy category |
|
Routes of administration | By mouth (gel capsule), intravenous |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | liver, kidney |
Elimination half-life | 10 minutes |
Excretion | kidney |
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Procarbazine is a
Common side effect include low blood cell counts and vomiting.[1] Other side effects include tiredness and depression.[2][3] It is not recommended in people with severe liver or kidney problems.[4] Use in pregnancy is known to harm the baby.[1] Procarbazine is in the alkylating agents family of medication.[1] How it works is not clearly known.[1]
Procarbazine was approved for medical use in the United States in 1969.[1] It is on the World Health Organization's List of Essential Medicines.[5][6] In the United Kingdom a month of treatment cost the National Health Service 450 to 750 pounds.[4]
Medical uses
When used to treat
Dose should be adjusted for kidney disease or liver disease.
Side effects
Very common (greater than 10% of people experience them) adverse effects include loss of appetite, nausea and vomiting.
When combined with ethanol, procarbazine may cause a disulfiram-like reaction in some people.[2]
It weakly inhibits MAO in the gastrointestinal system, so it can cause hypertensive crises if associated with the ingestion of tyramine-rich foods such as aged cheeses; this appears to be rare.[2]
Procarbazine rarely causes chemotherapy-induced peripheral neuropathy,[7] a progressive, enduring, often irreversible tingling numbness, intense pain, and hypersensitivity to cold, beginning in the hands and feet and sometimes involving the arms and legs.[8]
Pharmacology
Procarbazine works, in part, as an
References
- ^ a b c d e f g h "Procarbazine Hydrochloride". The American Society of Health-System Pharmacists. Archived from the original on 21 December 2016. Retrieved 8 December 2016.
- ^ a b c d e "Procarbazine Capsules 50mg – Summary of Product Characteristics". UK Electronic Medicines Compendium. 24 November 2014. Archived from the original on 20 December 2016.
- ISBN 9789241547659.
- ^ ISBN 9780857111562.
- hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
- ^ DeAngelis LM, Posner JS (2003). "Nonmetastatic Complications". In Kufe DW, Pollock RE, Weichselbaum RR, et al. (eds.). Holland-Frei Cancer Medicine (6th ed.). Hamilton (ON): BC Decker. Archived from the original on 2017-09-11.
- ^ del Pino BM (Feb 23, 2010). "Chemotherapy-induced Peripheral Neuropathy". NCI Cancer Bulletin. 7 (4): 6. Archived from the original on 2011-12-11.
- PMID 20625128.
- ISBN 978-0-12-088410-0. Retrieved 1 January 2021.
External links
- MOPP Treatment Regimen
- PCV Information
- Procarbazine Drug Information Provided by Lexi-Comp – Merck Manual
- RX Listing for Matulane
- "Procarbazine". Drug Information Portal. U.S. National Library of Medicine.